# A Study to Learn More About the Safety of a Single Dose of BIIB144 and How it is Processed in the Body of Healthy Adult Participants Ages 18 to 55 Years Old as Compared to a Placebo

> **NCT07662148** · PHASE1 · RECRUITING · sponsor: **Biogen** · enrollment: 48 (estimated)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** BIIB144
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07662148
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-21
- **Primary completion:** 2028-06-19
- **Final completion:** 2028-06-19
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2026-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07662148

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07662148, "A Study to Learn More About the Safety of a Single Dose of BIIB144 and How it is Processed in the Body of Healthy Adult Participants Ages 18 to 55 Years Old as Compared to a Placebo". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07662148. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*